Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ROCKVILLE, Md., June 09, 2026 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) announced the launch of FSGS in Focus, a national education awareness campaign to increase patient and...
-
Synklino announces treatment of first patient in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation.
-
ROCKVILLE, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) announced a significant expansion of its Kidney Health Coach® (KHC) community health education program,...
-
Eledon to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at ATC
-
SERB Pharmaceuticals to acquire development and commercialisation rights to Idefirix® (imlifidase) in Europe and MENA from Hansa Biopharma for €115 million
-
ROCKVILLE, Md., May 18, 2026 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) announced today that it is launching a two-year, quarterly professional education curriculum for interdisciplinary...
-
Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
ROCKVILLE, Md., May 07, 2026 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) released its sixth annual State of the States: Living Donor Protection Report Card. While AKF has helped lead...
-
ROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Thirty-five American Kidney Fund (AKF) Ambassadors from more than 20 states are joining AKF on Capitol Hill today to advocate for legislation...
-
ROCKVILLE, Md., April 28, 2026 (GLOBE NEWSWIRE) -- Today marks the third annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day, a day established by the American Kidney Fund (AKF) to encourage...